Corrigendum to “The soluble nectin-4 ecto-domain promotes breast cancer induced angiogenesis via endothelial Integrin-β4” [Int J Biochem Cell Biol, 2018, Sep, 102, 151–160]

Author(s):  
Sumit Siddharth ◽  
Anmada Nayak ◽  
Sarita Das ◽  
Deepika Nayak ◽  
Jyochanamayi Panda ◽  
...  
Keyword(s):  
Oncogene ◽  
2010 ◽  
Vol 29 (36) ◽  
pp. 5032-5047 ◽  
Author(s):  
K M Draheim ◽  
H-B Chen ◽  
Q Tao ◽  
N Moore ◽  
M Roche ◽  
...  

Cancers ◽  
2018 ◽  
Vol 10 (12) ◽  
pp. 507 ◽  
Author(s):  
Young Soung ◽  
Shane Ford ◽  
Cecilia Yan ◽  
Jun Chung

Despite the established role of integrin β4 (ITG β4) in breast cancer progression, the importance of endocytic recycling of ITG β4 and its regulatory mechanism are poorly understood. Here, we found that a sub-population of ITG β4 is sorted into early endosomes, recycled back to the plasma membrane, and secreted in the form of extracellular vesicles (EVs) upon EGF treatment in triple negative breast cancer (TNBC) cells. A metastasis suppressor, ARRDC3 (arrestin domain-containing 3) prevents EGF-driven endocytic recycling of ITG β4 by inducing NEDD4-dependent ubiquitination of ITG β4 and targeting endosomal ITG β4 into lysosomes. Endocytic recycling of ITG β4 is linked to sorting of ITG β4 into EVs (ITG β4+ EVs). ITG β4+ EVs are mainly detectable from supernatants of TNBC cells and their production is inhibited by ARRDC3 expression. ARRDC3 reduces the metastatic potentials of breast cancer cell-derived EVs by reducing ITG β4 levels in EVs. Overall, current studies provide novel mechanistic insights on the regulatory mechanism of ITG β4 recycling, and its importance in invasive potentials of TNBC EVs, thus providing the basis for therapeutic targeting of the ARRDC3/ITG β4 pathway in TNBC.


2018 ◽  
Vol 102 ◽  
pp. 151-160 ◽  
Author(s):  
Sumit Siddharth ◽  
Anmada Nayak ◽  
Sarita Das ◽  
Deepika Nayak ◽  
Jyochanamayi Panda ◽  
...  
Keyword(s):  

PLoS ONE ◽  
2015 ◽  
Vol 10 (5) ◽  
pp. e0125399 ◽  
Author(s):  
David T. Coleman ◽  
Young Hwa Soung ◽  
Young-Joon Surh ◽  
James A. Cardelli ◽  
Jun Chung

2018 ◽  
Vol 217 (2) ◽  
pp. 445-446 ◽  
Author(s):  
Hyungsoo Kim ◽  
Ze’ev A. Ronai

Although numerous pathways are known to control the tumor suppressor protein p53, coordinated regulation of the p53–Notch axis by Numb may have an even more remarkable impact. In this issue, Colaluca at al. (2018. J. Cell Biol. https://doi.org/10.1083/jcb.201709092) reveal an unexpected role of a newly characterized Numb splice variant in the regulation of p53, which may have significant implications for therapeutic intervention in breast cancer.


PLoS ONE ◽  
2016 ◽  
Vol 11 (2) ◽  
pp. e0148301 ◽  
Author(s):  
Jar-Yi Ho ◽  
Fung-Wei Chang ◽  
Fong Shung Huang ◽  
Jui-Ming Liu ◽  
Yueh-Ping Liu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document